Bruker provides life science and material research solutions, including diagnostics and analytical instruments, self-described as high-value.

Bruker

LabToGo

Domain Not Resolving

HSTS

Google Font API

DNSSEC

Font Awesome

Organization Schema

Cloudflare CDN

Cloudflare Hosting

Person Schema

Cloudflare

Worker/Owner

Barbara PLISKA

Owner

Frank Andreas

President and General Manager

Frank Burgaezy

Fred Aron

Peter Raphaelian

Owner & Company President

Peter Storm

Raleigh Holman

President, Bruker Cellular Analysis

Yan Zhang

Global Director IT SAP Competence Center

Adrian Ursu

Human Resources

Amy Kan

Marc Kastner

William Linton

Frank Laukien

Robert Rosenthal

Gilles Martin

Chris Ingen

Richard Kniss

Stephen Fesik

Rohan Thakur

Jason Faessler

Vice President, Financial Planning and Analysis

President & CEO

President

Lance Kuhn

Director Of Customer Service

Senior Vice President

Scott Tarran

Service Operations Manager

Mark Munch

Haystack Oncology enables precision oncology to optimize treatment strategies.

Micro VC Funded Companies (Top 10K)

Manufacturing Companies (Top 10K)

United States Companies With More Than $10M in Revenue (Top 10K)

Massachusetts Public Companies With More Than $10M in Revenue

Bruker Corporation is a provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analysis.

Post-IPO Equity - Bruker

Post-IPO Debt - Bruker

Thomas Weisel Partners

Computer and Software Products and Electrical and Scientific Products

Billerica

Massachusetts

United States

North America

Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics

In Brief This Week: Bruker, Qiagen, Prenetics, CellChorus, T2 Biosystems, More

Bruker Announces Formation of New Bruker Spatial Biology Division

Bruker spools up spatial biology division from NanoString, Canopy assets

Bruker Introduces Innovative Neuroscience Research Solution with High-Speed OptoVolt Voltage Imaging

Bruker acquires Dynamic Biosensors, terms undisclosed

Bruker Acquires Dynamic Biosensors, a Pioneer of Single-Cell Interaction Cytometry Systems for Drug Discovery

Dynamic Biosensors–Bruker: investment, 202410 acquisition €na of Dynamic Biosensors GmbH + integration in Bruker Biosensors business

A technique that allows for the visualization of molecular distributions within tissue sections, aiding in spatial biology research.

A technique that uses mass spectrometry to visualize the spatial distribution of molecules in tissue sections, aiding in the understanding of complex biological systems.

A benchtop mass spectrometer that combines fast analysis speed with ease of operation for a wide range of applications, including protein and peptide analysis.

A mass spectrometry platform offering fast analysis and ease of operation for a range of biological applications.

An optical emission spectrometer designed for precise metal analysis, featuring advanced detection and thermal stability technologies.

An optical emission spectrometer designed for precise metal analysis, offering high precision and reliability in determining alloy compositions.

Germany

Europe

Saudi Arabia

Asia

China

Mexico

HTML5

Facebook Comments

Oktopost

Google Fonts

Twilio

Google Maps API

Adobe Fonts

Vimeo

Apache Server

Facebook

Bruker owns Bruker Optics

Bruker owns Bruker Energy & Supercon Technologies

Bruker owns Bruker BioSpin

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Bruker Corporation

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 19, 2024 2:26 AM	073a8691
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 19, 2024 2:26 AM	4206dc8b
crunchbase trigger	general	Nov 19, 2024 2:26 AM	9e4144b5
crunchbase profile	general	Nov 19, 2024 7:56 PM	8d5ad6ff
li profile	general	Nov 19, 2024 2:26 AM	621ebfe9
translate crunchbase fundingrounds	general	Nov 19, 2024 9:04 PM	0883e10d
peers	general	Nov 19, 2024 2:26 AM	37554dc9
news basic	general	Nov 19, 2024 2:26 AM	39493e29
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:BRUKER

Bruker

Last Close

53.37

21/11 21:00

Market Cap

9.27B

Beta: -

Volume Today

2.53M

Avg: -